James E. Berg serves as Executive at AVANIR PHARMACEUTICALS, where they oversee executive responsibilities. Since joining the company, James E. Berg has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on May 30, 2006 involved exercising options for 37,500 shares valued at $108.0K.
James E. Berg currently holds 53,000 shares of AVANIR PHARMACEUTICALS (AVN.R), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James E. Berg has been a net neutral trader of AVN.R stock. They have purchased $0 and sold $0 worth of shares.
James E. Berg's most recent insider trade was on May 30, 2006, when they sold 37,500 shares at $2.88 per share.
Get notified when new Form 4 filings are submitted
| 750 |
| $10.00 |
| Discretionary |
| Mar 1, 2006 | AVN.R | $14.7K | Option Exercise | 2,500 | $5.88 | Discretionary |